SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback